MPWT
BPMC

MassMutual Private Wealth & Trust’s Blueprint Medicines BPMC Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-31
Closed -$3.97K – 2375
2025
Q2 		$3.97K Buy
31
+16
+107% +$1.66K ﹤0.01% 1723
2025
Q1 		$1.33K Buy
15
+1
+7% +$98 ﹤0.01% 2043
2024
Q4 		$1.22K Buy
14
+2
+17% +$183 ﹤0.01% 1975
2024
Q3 		$1.11K Sell
12
-1
-8% -$99 ﹤0.01% 1831
2024
Q2 		$1.4K Buy
13
+3
+30% +$300 ﹤0.01% 1742
2024
Q1 		$949 Buy
10
+8
+400% +$686 ﹤0.01% 1717
2023
Q4 		$184 Hold
2
– – ﹤0.01% 1916
2023
Q3 		$100 Buy
+2
New +$107 ﹤0.01% 1948
2022
Q4 		– Sell
-25
Closed -$2K – 1659
2022
Q3 		$2K Buy
25
+16
+178% +$1.03K ﹤0.01% 1177
2022
Q2 		$0 Buy
+9
New +$527 ﹤0.01% 1526
2022
Q1 		– Sell
-6
Closed -$1K – 1518
2021
Q4 		$1K Buy
+6
New +$628 ﹤0.01% 1177

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MassMutual Private Wealth & Trust's BPMC Position: Q3 2025 in Review

MassMutual Private Wealth & Trust sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 31 shares — an estimated $3.97K sold.

MassMutual Private Wealth & Trust first reported a position in BPMC in Q4 2021 and held it in 11 quarters. The position peaked at $3.97K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • MassMutual Private Wealth & Trust reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 31 Blueprint Medicines shares in Q3 2025, an estimated $3.97K.
  • MassMutual Private Wealth & Trust first reported a position in Blueprint Medicines in Q4 2021 and held it in 11 quarters.
  • MassMutual Private Wealth & Trust's Blueprint Medicines position peaked at $3.97K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2025, filed 22 Oct 2025.